Comments

BridgeBio Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BBIONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$35.11

-1.29-3.54%

At close: -

$35.00

-0.11-0.31%

After Hours: 4:01 PM EDT

BridgeBio Pharma (BBIO) Forecast

News Earnings BridgeBio Pharma (BBIO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

BridgeBio Pharma Stock Price, Quotes and Forecasts | NASDAQ:BBIO | Benzinga

Explore BridgeBio Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BBIO.

Open	$35.98
Close	$35.11
Volume / Avg.	1.19M / 2.99M
Day Range	$34.97 - $36.40
52 Wk Range	21.62 - 39.47
Market Cap	$6.66B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	17.5%
Days to Cover	6.84

Recent News

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

BridgeBio's acoramidis wins Japan's approval for ATTR-CM. Phase 3 data show a 42% reduction in key heart-related events. AstraZeneca's Alexion to market it.

Vandana Singh

Top 4 Health Care Stocks You May Want To Dump In Q1

Avi Kapoor

Gold Down Over 3%; Rigetti Computing Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$35.98
Close	$35.11
Volume / Avg.	1.19M / 2.99M
Day Range	$34.97 - $36.40
52 Wk Range	21.62 - 39.47
Market Cap	$6.66B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	17.5%
Days to Cover	6.84

About BridgeBio Pharma Inc

Sector

Health Care

Industry

Biotechnology

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and deliver...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BridgeBio Pharma (BBIO) stock?

You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.

View our list of the best stock brokerages

Who are BridgeBio Pharma (BBIO) competitors?

Other companies in BridgeBio Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?

BridgeBio Pharma has a consensus price target of $46.33.

What is the current price for BridgeBio Pharma (BBIO)?

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $35 last updated March 28, 2025 at 4:01 PM EDT.

Does BridgeBio Pharma (BBIO) pay a dividend?

There are no upcoming dividends for BridgeBio Pharma.

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

BridgeBio Pharma’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is BridgeBio Pharma (BBIO) going to split?

There is no upcoming split for BridgeBio Pharma.

What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.